Blog

Older Patients with Metastatic Melanoma May Benefit from Immunotherapy – Curetoday.com

Older Patients with Metastatic Melanoma May Benefit from Immunotherapy
Curetoday.com
Age should not limit which patients with metastatic melanoma receive immunotherapy, according to a new study published in JAMA Dermatology. In fact, study findings showed that patients aged 65 years and older experienced better overall survival (OS

2018-04-25 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.